Canadian Association of Professionals in Regulatory Affairs | CAPRA

CAPRA BENEFITS

The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is an organization dedicated to providing its members with opportunities to enhance their professional development and maximize career opportunities. Whether you are a student, an entry-level associate or an experienced executive, a membership with CAPRA is a must.

We foster learning, networking and professional excellence of our members. We will build and strengthen relationships with governmental agencies, scientific experts and industry educators in order to create an affordable, professionally fulfilling and academically enriching environment for our members.

students joining CAPRA

WHY JOIN CAPRA AS A STUDENT?

For any full-time student in the Regulatory Programme qualifies to purchase a Student Membership.

BENEFITS

Save on event pricing!

  • NOC Magazine subscription
  • CAPRA Member Directory access
  • Volunteering  opportunities
  • Access to job listings and members-only content

Consultant Directory


Focal Point Research Inc.

Focal Point Research Inc.

Focal Point Research is a unique consulting company, which has the ability to assist with regulatory approvals, label & ingredient compliance, quality assurance and beyond....
Allucent

Allucent

Allucent delivers innovative strategies and robust solutions based on over 30 years of background in regulatory trends, therapeutic experience, and operational expertise. We...
Lezayre e-Submissions Ltd.

Lezayre e-Submissions Ltd.

• Lezayre e-Submissions Ltd. was founded in 2015 and is located on the West Coast of Canada • We provide support for document formatting (Modules 1 – 5) and Regulatory eCTD...

ADVERTISE WITH CAPRA

Reach CAPRA members through the NOC (News of Course), or place an employment ad in our listings.

CAPRA BLOG


Rethinking Cost-Sharing: The Need for Health Insurance Reform in the U.S.
Rethinking Cost-Sharing: The Need for Health Insurance Reform in the U.S.
In the U.S., the system designed to protect Americans from the financial devastation of illness often ends up being the very source of that devastation. While it can be...
Value-Based Drug Pricing in Canada and its Limitations
Value-Based Drug Pricing in Canada and its Limitations
Drug pricing is a complex and controversial issue that often sparks debates among patients, pharmaceutical companies, and the government. Prices can vary significantly...
Addressing Underrepresentation in Clinical Trials: FDA's Diversity Action Plan
Addressing Underrepresentation in Clinical Trials: FDA's Diversity Action Plan
The U.S. Food and Drug Administration (FDA) released a new draft guidance in June 2024 to enhance the diversity of clinical trial participants. The guidance details the...